EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clomiphene citrate and human chorionic gonadotropin treatment before microdissection testicular sperm extraction in non-obstructive azoospermia: a retrospective non-randomized series

Mohammad Al-Zubi, Mohammad Ghassab Deameh, Ahmed Khaled Awawdeh, Rahaf Jamil Mohammad, Ayah Ahmad Shannaq, Salma Mo'taz Qdisat, Ruba Mahmoud Mansi, Anas Yousef Tanashat, Mohammad Ahmad Mubarak, Balqis Abu-Khadra, Morad Bani-Hani

Frontiers in Reproductive Health · 20.04.2026 · 8

DOI: 10.3389/frph.2026.1696244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Reproductive Health, online erschienen am 20.04.2026. Verfasst von Mohammad Al-Zubi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Anesthesia, Division of Urology, Faculty of Medicine, Yarmouk University, Irbid, Jordan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Infertility is defined as the inability to conceive after 12 months or longer of regular unprotected sexual intercourse. Azoospermia affects approximately 1% of men, with non-obstructive azoospermia (NOA) accounting for nearly 60% of cases. The role of hormonal treatment before microdissection testicular sperm extraction (Micro-TESE) in stimulating spermatogenesis in patients with NOA is controversial. From this standpoint, our study aimed to investigate the effect of preoperative hormonal treatment on sperm retrieval rates (SRRs) during Micro-TESE in NOA patients. Materials and methods A retrospective analysis was conducted on 152 patients who underwent Micro-TESE for NOA at our center between January 2021 and December 2023. Patients were divided into two groups. The first group included patients who received preoperative hormonal therapy consisting of clomiphene citrate (25 mg daily) and subcutaneous human chorionic gonadotropin injections (2,000 IU three times weekly) for at least 3 months prior to Micro-TESE, while the second group did not. The two groups were compared for the presence of viable sperm, age, smoking status, medical illnesses (diabetes mellitus and hypertension), hormonal profile before operation [follicle-stimulating hormone (FSH), luteinizing hormone, and total testosterone], history of undescended testes, and the presence of Klinefelter syndrome. Statistical significant was defined as p -value < 0.05.

Results

A total of 152 NOA patients were included in this study, with 78 patients undergoing preoperative hormonal therapy and 74 patients not receiving any preoperative hormonal therapy. Results revealed no statistically significant differences in most demographic and clinical parameters between the groups. Hormonal analysis revealed a significantly lower median FSH level in the preoperative hormonal therapy group ( p = 0.04). Micro-TESE outcomes were also comparable, with 50% success in the non-hormonal therapy group and 45% in the preoperative hormonal therapy group ( p = 0.53).

Conclusion

In this retrospective cohort, preoperative hormonal therapy was not associated with a statistically significant improvement in Micro-TESE sperm retrieval outcomes in NOA patients. Further studies are warranted to identify biomarkers predicting responders to preoperative hormonal stimulation.

Schlagwörter

Stichwörter der Autor:innen

Micro-TESEazoospermiahormonal therapymale infertilitysperm retrieval

Autor:innen und Institutionen

  • Department of Surgery and Anesthesia, Division of Urology, Faculty of Medicine, Yarmouk University, Irbid, Jordan.
  • Division of Urology, Department of Surgery, Prince Hamza Hospital, Amman, Jordan.
  • Faculty of Medicine, Yarmouk University, Irbid, Jordan.
  • Department of General Surgery and Urology, Faculty of Medicine, Hashemite University, Zarqa, Jordan.

Zitieren

APA

Al-Zubi, M., Ghassab Deameh, M., Awawdeh, A. K., Mohammad, R. J., Shannaq, A. A., Qdisat, S. M., Mansi, R. M., Tanashat, A. Y., Mubarak, M. A., Abu-Khadra, B., & Bani-Hani, M. (2026). Clomiphene citrate and human chorionic gonadotropin treatment before microdissection testicular sperm extraction in non-obstructive azoospermia: a retrospective non-randomized series. Frontiers in Reproductive Health, 8. https://doi.org/10.3389/frph.2026.1696244

Vancouver

Al-Zubi M, Ghassab Deameh M, Awawdeh AK, Mohammad RJ, Shannaq AA, Qdisat SM, et al. Clomiphene citrate and human chorionic gonadotropin treatment before microdissection testicular sperm extraction in non-obstructive azoospermia: a retrospective non-randomized series. Frontiers in Reproductive Health. 2026;8. doi:10.3389/frph.2026.1696244

BibTeX
@article{AlZubi2026,
  author = {Al-Zubi, Mohammad and Ghassab Deameh, Mohammad and Awawdeh, Ahmed Khaled and Mohammad, Rahaf Jamil and Shannaq, Ayah Ahmad and Qdisat, Salma Mo'taz and Mansi, Ruba Mahmoud and Tanashat, Anas Yousef and Mubarak, Mohammad Ahmad and Abu-Khadra, Balqis and Bani-Hani, Morad},
  title = {Clomiphene citrate and human chorionic gonadotropin treatment before microdissection testicular sperm extraction in non-obstructive azoospermia: a retrospective non-randomized series},
  journal = {Frontiers in Reproductive Health},
  year = {2026},
  volume = {8},
  doi = {10.3389/frph.2026.1696244}
}
Kostenlos starten →